Chemesis International Inc. Acquires Intellectual Property for High-Quality Cannabis Extraction
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. Acquires Intellectual Property for High-Quality Cannabis
Extraction
Chemesis acquires the IP and physical extraction equipment for a methodology that utilizes a low-temperature
process to produce a high concentration cannabis oil that preserves all constituents and phytocannabinoids
February 7, 2019
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces it has acquired intellectual property (“IP”) and the physical equipment for an
extraction methodology to preserve all of the phytocannabinoids and terpenes from cannabis utilizing a
low-temperature process to create “live resin”. The method will allow the Company to produce a unique
variety of finished goods such as tinctures, shatters, vapes, oils and other consumer products that can
be varied to achieve desired potencies of different cannabinoids and terpenes.
The Company will relocate the extraction assets, which are currently situated in a licensed facility in San
Diego County, CA, to its extraction facility in Cathedral City, CA. The sales staff will be retained and
integrated into the Chemesis operations with the focus expanding to the entire family of brands. This
will provide the Company a third extraction method to complement its current ethanol and butane hash
oil (BHO) methods. The low temperature extraction will preserve 100% of the natural cannabinoids,
increasing yields and eliminating many of the operating costs normally associated with other method
processes such as winterization, filtration and evaporation.
This new methodology w ill allow the Company to bring forward a variety of new products to the
marijuana and hemp markets that have not been altered by high heat or solvents, which can degrade
the quality of cannabinoids. With this transaction, the Company has initial monthly purchase orders in
excess of $200,000USD.
“The new IP we have acquired will allow Chemesis to manufacture products for consumers that will be
among the highest quality and potency in the market,” said CEO, Edgar Montero. “Chemesis intends to
leverage this technology throughout our family of brands to target consumers that are looking for both
high quality and cannabinoid entourage effects. The Company also believes the addition of this IP
showcases our continued focus on products that are leading the industr y in both extraction
methodology and product innovation.”
Under the terms of this acquisition, Chemesis will issue 1,597,633 shares priced at a deemed value of
$1.69CDN. The stock issued is subject to 36-month lock-up/leak-out guidelines.
On Behalf of The Board of Directors
Edgar Montero
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently
operating within California, Puerto Rico, and Colombia.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution
and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective
production and distribution of its products. In addition, Chemesis leverages exclusive brands and
partnerships and uses the highest quality extraction methods to provide consumers with quality
cannabis products.
Chemesis will add shareholder value by exploring opportunities in emerging markets while consistent ly
delivering quality product to its consumers from seed to sale.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
CaliforniaSap.instagram
Jay&SB.instagram
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Company’s business, its product offerings and plans for sales and marketing, including finalizing an acquisition in
Colombia. Although the Company believes that the expectations reflected in the forward -looking information are
reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to
place undue reliance on forward -looking information. Such forward -looking statements are subject to risks and
uncertainties that may cause actual results, performance and developments to differ materially from those
contemplated by the se statements depending on, among other things, the risks that the Company's products and
plan will vary from those stated in this news release and the Company may not be able to carry out its business
plans as expected. Except as required by law, the Comp any expressly disclaims any obligation and does not intend
to update any forward -looking statements or forward -looking information in this news release. Although the
Company believes that the expectations reflected in the forward -looking information are re asonable, there can be
no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales
reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release